Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Cogito Ergo Sum who wrote (25552)	11/22/2007 7:24:44 AM
From: elmatador	Read Replies (1) \| Respond to of 217659

The WHO subsidizes the research of drugs, thus they have to have a say on that matter. The WHO provides that kind of research that the commercial laboratories are not interested in. For example: heart diseases and fat people’s diseases has a lot of interest of the laboratories. That because they see a commercial interest on those drugs. No one is interested in producing drugs that cure epidemic disease to sell in Burkina Faso. The WHO pays scientists to research those diseases and pass the research to universities that further handover the results to the commercial laboratories. Now you know about which labor’s fruits we are talking about. I am teaching you that (I gave up teaching MQ because his brain has calcified) because you don't know it. Only poor people can grasp the right perspective and the leaders take the initiative.